To determine whether tumor cell proliferation is inhibited in vivo by XEN445 treatment, we performed immunohistochemistry (IHC) analysis of Ki67, a cell proliferation marker, on vehicle- and XEN445-treated tumors. Here, MKI67 is linked to neoplasm.